BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 15287852)

  • 1. Induction of oral immune regulation towards liver-extracted proteins for treatment of chronic HBV and HCV hepatitis: results of a phase I clinical trial.
    Israeli E; Safadi R; Melhem A; Pappo O; Shibolet O; Klein A; Hemed N; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
    Liver Int; 2004 Aug; 24(4):295-307. PubMed ID: 15287852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of chronic hepatitis B virus infection via oral immune regulation toward hepatitis B virus proteins.
    Safadi R; Israeli E; Papo O; Shibolet O; Melhem A; Bloch A; Rowe M; Alper R; Klein A; Hemed N; Segol O; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
    Am J Gastroenterol; 2003 Nov; 98(11):2505-15. PubMed ID: 14638356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inducing oral immune regulation of hepatitis B virus envelope proteins suppresses the growth of hepatocellular carcinoma in mice.
    Gotsman I; Alper R; Klein A; Rabbani E; Engelhardt D; Ilan Y
    Cancer; 2002 Jan; 94(2):406-14. PubMed ID: 11900226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B.
    Zhang Z; Zhang JY; Wherry EJ; Jin B; Xu B; Zou ZS; Zhang SY; Li BS; Wang HF; Wu H; Lau GK; Fu YX; Wang FS
    Gastroenterology; 2008 Jun; 134(7):1938-49, 1949.e1-3. PubMed ID: 18455515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An outbreak of fulminant hepatitis B in immunocompromised hemodialysis patients.
    Igaki N; Nakaji M; Moriguchi R; Akiyama H; Tamada F; Oimomi M; Goto T
    J Gastroenterol; 2003; 38(10):968-76. PubMed ID: 14614604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Monitoring patients with chronic hepatitis during and after therapy].
    Colić-Cvrlje V; Mise S
    Acta Med Croatica; 2009 Dec; 63(5):377-83. PubMed ID: 20198895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral interaction and responses in chronic hepatitis C and B coinfected patients with interferon-alpha plus ribavirin combination therapy.
    Chuang WL; Dai CY; Chang WY; Lee LP; Lin ZY; Chen SC; Hsieh MY; Wang LY; Yu ML
    Antivir Ther; 2005; 10(1):125-33. PubMed ID: 15751770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-level hepatitis C viremia and humoral immune response to NS4 in chronic hepatitis B virus-hepatitis C virus coinfection.
    Chu CM; Sheen IS; Liaw YF
    Scand J Gastroenterol; 2004 Aug; 39(8):778-82. PubMed ID: 15513365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of liver T-cell receptor gammadelta T cells obtained from individuals chronically infected with hepatitis C virus (HCV): evidence for these T cells playing a role in the liver pathology associated with HCV infections.
    Tseng CT; Miskovsky E; Houghton M; Klimpel GR
    Hepatology; 2001 May; 33(5):1312-20. PubMed ID: 11343261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained and focused hepatitis B virus nucleocapsid-specific T-cell immunity in liver transplant recipients compared to individuals with chronic and self-limited hepatitis B virus infection.
    Bihl F; Loggi E; Chisholm JV; Biselli M; Morelli MC; Cursaro C; Terrault NA; Bernardi M; Bertoletti A; Andreone P; Brander C
    Liver Transpl; 2008 Apr; 14(4):478-85. PubMed ID: 18324666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Impaired non-viral specific immune function of dendritic cell does not interfere with clearance and cytotoxic T lymphocyte response to HBV or HCV].
    Fan CL; Chen HS; Li RB; Wang SX; Cong X; Fei R; Jiang D; Wang Y; Wei L
    Zhonghua Gan Zang Bing Za Zhi; 2004 Feb; 12(2):67-71. PubMed ID: 14980100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different composition of intrahepatic lymphocytes in the immune-tolerance and immune-clearance phase of chronic hepatitis B.
    Sprengers D; van der Molen RG; Kusters JG; Hansen B; Niesters HG; Schalm SW; Janssen HL
    J Med Virol; 2006 May; 78(5):561-8. PubMed ID: 16555293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunopathology of chronic liver diseases].
    Meyer zum Büschenfelde KH
    Verh Dtsch Ges Pathol; 1995; 79():186-97. PubMed ID: 8600684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amelioration of non-alcoholic steatohepatitis and glucose intolerance in ob/ob mice by oral immune regulation towards liver-extracted proteins is associated with elevated intrahepatic NKT lymphocytes and serum IL-10 levels.
    Elinav E; Pappo O; Sklair-Levy M; Margalit M; Shibolet O; Gomori M; Alper R; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
    J Pathol; 2006 Jan; 208(1):74-81. PubMed ID: 16261527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severity of liver disease predicts the development of glucose abnormalities in patients with chronic hepatitis B or C following achievement of sustained virological response to antiviral therapy.
    Chehadeh W; Al-Nakib W
    J Med Virol; 2009 Apr; 81(4):610-8. PubMed ID: 19235842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections.
    Oliviero B; Varchetta S; Paudice E; Michelone G; Zaramella M; Mavilio D; De Filippi F; Bruno S; Mondelli MU
    Gastroenterology; 2009 Sep; 137(3):1151-60, 1160.e1-7. PubMed ID: 19470388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization with a DNA vaccine candidate in chronic hepatitis C patients is safe, well tolerated and does not impair immune response induction after anti-hepatitis B vaccination.
    Castellanos M; Cinza Z; Dorta Z; Veliz G; Vega H; Lorenzo I; Ojeda S; Dueñas-Carrera S; Alvarez-Lajonchere L; Martínez G; Ferrer E; Limonta M; Linares M; Ruiz O; Acevedo B; Torres D; Márquez G; Herrera L; Arús E
    J Gene Med; 2010 Jan; 12(1):107-16. PubMed ID: 19866482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine-dependent anti-viral role of CD4-positive T cells in therapeutic vaccination against chronic hepatitis B viral infection.
    Ren F; Hino K; Yamaguchi Y; Funatsuki K; Hayashi A; Ishiko H; Furutani M; Yamasaki T; Korenaga K; Yamashita S; Konishi T; Okita K
    J Med Virol; 2003 Nov; 71(3):376-84. PubMed ID: 12966542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrahepatic virus-specific IL-10-producing CD8 T cells prevent liver damage during chronic hepatitis C virus infection.
    Abel M; Sène D; Pol S; Bourlière M; Poynard T; Charlotte F; Cacoub P; Caillat-Zucman S
    Hepatology; 2006 Dec; 44(6):1607-16. PubMed ID: 17133491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virus-specific T cell immune response in children and adolescents with chronic hepatitis B virus infection.
    Fischler B; Nyström J; Björnsdottir T; Lindh G; Hultgren C
    J Pediatr Gastroenterol Nutr; 2007 Jul; 45(1):75-83. PubMed ID: 17592368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.